Low-dose tenofovir is more potent than adefovir and is effective in controlling HBV viremia in chronic HBeAg-negative hepatitis B. (Q34382099)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Low-dose tenofovir is more potent than adefovir and is effective in controlling HBV viremia in chronic HBeAg-negative hepatitis B. |
scientific article |
Statements
1 reference
Low-dose tenofovir is more potent than adefovir and is effective in controlling HBV viremia in chronic HBeAg-negative hepatitis B. (English)
1 reference
Paolo Del Poggio
1 reference
Maurizio Zaccanelli
1 reference
Maria Oggionni
1 reference
Silvia Colombo
1 reference
Carlo Jamoletti
1 reference
Vesna Puhalo
1 reference
1 August 2007
1 reference
1 reference
13
1 reference
30
1 reference
4096-4099
1 reference
Identifiers
1 reference
1 reference
1 reference